Carcavilla, A.; Cambra, A.; Santomé, J.L.; Seidel, V.; Cruz, J.; Alonso, M.; Pozo, J.; Valenzuela, I.; Guillén-Navarro, E.; Santos-Simarro, F.;
et al. Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment. J. Clin. Med. 2023, 12, 5003.
https://doi.org/10.3390/jcm12155003
AMA Style
Carcavilla A, Cambra A, Santomé JL, Seidel V, Cruz J, Alonso M, Pozo J, Valenzuela I, Guillén-Navarro E, Santos-Simarro F,
et al. Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment. Journal of Clinical Medicine. 2023; 12(15):5003.
https://doi.org/10.3390/jcm12155003
Chicago/Turabian Style
Carcavilla, Atilano, Ana Cambra, José L. Santomé, Verónica Seidel, Jaime Cruz, Milagros Alonso, Jesús Pozo, Irene Valenzuela, Encarna Guillén-Navarro, Fernando Santos-Simarro,
and et al. 2023. "Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment" Journal of Clinical Medicine 12, no. 15: 5003.
https://doi.org/10.3390/jcm12155003
APA Style
Carcavilla, A., Cambra, A., Santomé, J. L., Seidel, V., Cruz, J., Alonso, M., Pozo, J., Valenzuela, I., Guillén-Navarro, E., Santos-Simarro, F., González-Casado, I., Rodríguez, A., Medrano, C., López-Siguero, J. P., & Ezquieta, B.
(2023). Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment. Journal of Clinical Medicine, 12(15), 5003.
https://doi.org/10.3390/jcm12155003